Cornea Centre, Chandigarh, India.
Am J Ophthalmol. 2012 Dec;154(6):922-926.e1. doi: 10.1016/j.ajo.2012.06.005. Epub 2012 Sep 7.
To present a new complication of persistent corneal edema after collagen cross-linking (CXL) in keratoconus patients.
Retrospective case series of postoperative corneal edema after CXL.
study population: All patients who underwent CXL treatment with subsequent corneal edema. Patients with stromal haze were excluded. intervention: The CXL treatments used the Dresden protocol with corneal thickness of more than 400 μm after epithelium was removed. main outcome measure: The resolution of corneal edema after surgery.
Postoperative corneal edema was identified in 10 (2.9%) of 350 patients who were followed up for a mean of 14 ± 4 months. The edema started on postoperative day 1 (10/10) and increased for 3 weeks. Additional findings included: deep vascularization (2 eyes; 20%), iris atrophy (6 eyes; 60%), pigment dispersion (5 eyes; 50%), persistent epithelial defect (3 eyes; 30%), and infectious keratitis (1 eye; 10%). Specular microscopy was unsuccessful, but the fellow untreated eyes had normal endothelial counts. Intraocular pressure and lenticular evaluations were normal. Corneal edema improved in 4 patients and resolved in 1 patient. In these 5 patients, the logarithm of the minimal angle of resolution best-corrected visual acuity was 0.5 ± 0.18. Penetrating keratoplasty was offered to 5 patients when improvement plateaued at 3 months, but only 2 patients underwent penetrating keratoplasty.
CXL is a safe and effective procedure with few known side effects. This case series reports the possibility of corneal endothelial damage with visually significant corneal edema after CXL treatment. Based on the extent of endothelial damage, patients may require penetrating keratoplasty.
介绍角膜交联术后持续性角膜水肿的一种新并发症。
交联术后角膜水肿的回顾性病例系列。
研究人群:所有接受 CXL 治疗后出现角膜水肿的患者。排除基质混浊的患者。干预措施:采用德累斯顿方案进行 CXL 治疗,上皮去除后角膜厚度大于 400μm。主要观察指标:术后角膜水肿的消退情况。
350 例患者平均随访 14±4 个月,其中 10 例(2.9%)发生术后角膜水肿。水肿于术后第 1 天(10/10)开始出现,并持续增加 3 周。其他发现包括:深层血管化(2 眼;20%)、虹膜萎缩(6 眼;60%)、色素播散(5 眼;50%)、持续性上皮缺损(3 眼;30%)和感染性角膜炎(1 眼;10%)。共焦显微镜检查不成功,但对侧未治疗眼的内皮细胞计数正常。眼压和晶状体评估正常。4 例患者的角膜水肿改善,1 例患者的角膜水肿消退。在这 5 例患者中,最佳矫正视力的最小分辨角对数为 0.5±0.18。当 3 个月时改善达到平台期时,向 5 例患者提供了穿透性角膜移植术,但只有 2 例患者接受了穿透性角膜移植术。
CXL 是一种安全有效的治疗方法,已知的副作用较少。本病例系列报告了 CXL 治疗后可能出现角膜内皮损伤导致明显的角膜水肿。根据内皮损伤的程度,患者可能需要穿透性角膜移植术。